<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940202-2-00110</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=11 g=1 f=1 --> In hospitals where the heated-water system has been identified as the source of the organism, the system has been decontaminated by pulse (one-time) thermal disinfection or superheating (i.e., flushing for at least 5 minutes each distal outlet of the hot-water system with water at "65 <!-- PJG 0017 degreeslatlong --> &cir;C) and hyperchlorination (flushing all outlets of the hot-water system with water containing "10 mg/L free residual chlorine). <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 403,408&hyph;410 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Following either of these procedures, most hospitals maintain heated-water at "50 <!-- PJG 0017 degreeslatlong --> &cir;C or &lt;20 <!-- PJG 0017 degreeslatlong --> &cir;C at the tap or chlorinate heated water to achieve 1&hyph;2 mg/L free residual chlorine at the tap. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 338,383,393,400&hyph;403 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Additional measures, such as physical cleaning or replacement of hot-water storage tanks, water-heaters, faucets, and showerheads, may be required because scale and sediment that provide organisms protection from the biocidal effects of heat and chlorine, may accumulate in them. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 346,403 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Alternative methods for control and eradication of legionellae in water systems, such as treatment of water with ozone, ultraviolet light, or heavy metal ions, have limited the growth of legionellae under laboratory, <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 344,411,412 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  or, in the case of ultraviolet light, operating conditions. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 413 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  However, further data are needed regarding the efficacy of these methods when used in hospital water systems <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 414 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  before they can be considered standard. In hospitals where the cooling towers are contaminated, measures for decontamination have been previously published. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 415 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> For highly immunocompromised patients, other preventive measures have been used. At one hospital, immunosuppressed patients were restricted from taking showers, and, for these patients, only sterile water was used for drinking or flushing nasogastric tubes; <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 384 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  In another hospital, a combined approach, consisting of continuous heating, particulate filtration, ultraviolet treatment, and monthly pulse hyperchlorination of the water supply of the bone-marrow transplant unit, was used to decrease the incidence of Legionnaires' disease. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 413 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> In view of the high cost of an environmental investigation and of instituting control measures to eradicate  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Legionella <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  spp. from sources in the hospital <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 416,417 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  and the differential risk, based on host factors, for acquiring nosocomial legionellosis and of having severe and fatal infection with the microorganism, the decision to search for and the choice of procedures to eradicate hospital environmental sources of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Legionella <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  spp. should take into account the type of patient population served by the hospital.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=74 g=1 f=1 --> ASPERGILLOSIS  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> I. Epidemiology  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Aspergillus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  spp. are ubiquitous fungi, commonly occurring in soil, water, and decaying vegetation.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Aspergillus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  spp. have been cultured from unfiltered air, ventilation systems, contaminated dust dislodged during hospital renovation and construction, horizontal surfaces, food, and ornamental plants. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 418 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> A. fumigatus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  and  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> A. flavus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  are the most frequently isolated  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Aspergillus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  spp. in patients with proven aspergillosis. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 419 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Nosocomial aspergillosis has been recognized increasingly as a cause of severe illness and mortality in highly immunocompromised patients, e.g., patients undergoing chemotherapy and/or organ transplantation, including bone-marrow transplantation for hematologic and other malignant neoplasms. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 420&hyph;423 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> The most important nosocomial infection due to  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Aspergillus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  spp. is pneumonia. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 424 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Hospital outbreaks of pulmonary aspergillosis have occurred mainly in granulocytopenic patients, especially in bone-marrow transplant units. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 424&hyph;430 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Although invasive aspergillosis has been reported in recipients of solid-organ transplants (e.g., heart or kidney), <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 431&hyph;435 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  the incidence of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Aspergillus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  spp. infections in these patients has been lower than in recipients of bone-marrow transplants, probably because of the recent decrease in the use of corticosteroids and the introduction of cyclosporine. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 433,436 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  In solid-organ transplant recipients, the efficacy of infection control measures, such as provision of protected environments and prophylaxis with antifungal agents, in preventing aspergillosis has not been well evaluated. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 433,434,437&hyph;439 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  In one study of heart-transplant recipients, protective isolation of patients alone failed to prevent fungal infections. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 440 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> The reported attributable mortality from invasive pulmonary aspergillosis has varied, depending on the patient population studied. Rates have been as high as 95% in recipients of allogeneic bone-marrow transplants and patients with aplastic anemia, compared with rates of 13&hyph;80% in leukemic patients. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 441&hyph;443 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> II. Pathogenesis  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> In contrast to most bacterial pneumonias, the primary route of acquiring  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Aspergillus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  sp. infection is by inhalation of the fungal spores. In severely immunocompromised patients, primary  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Aspergillus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  spp. pneumonia results from local lung tissue invasion. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 419,444,445 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Subsequently, the fungus may disseminate via the bloodstream to involve multiple other deep organs. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 419,445,446 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  A role for nasopharyngeal colonization with  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Aspergillus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  spp., as an intermediate step before invasive pulmonary disease, has been proposed, but remains to be elucidated. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 438,447,448 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  On the other hand, colonization of the lower respiratory tract by  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Aspergillus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  spp., especially in patients with preexisting lung disease such as chronic obstructive lung disease, cystic fibrosis, or inactive tuberculosis, has predisposed patients to invasive pulmonary and/or disseminated infection. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 419,445,449 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            